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Abstract
Background: In Africa, especially in West Africa, studies about the prevalence and diversity of respiratory viruses
(influenza and others) in elderly people are largely lacking. In studies done elsewhere, it is well established that
older people, when compared with younger adults, are at greater risk of significant morbidity and mortality from
complications arising from influenza. The main aim of this study was to determine the prevalence and the diversity
of respiratory viruses associated with ILI cases in adults over 50 years old in Senegal.
Methods: The recruitment period of this study was from January 2009 to December 2011. 232 patients aged
50 years and above presenting ILI cases were enrolled. Nasal-pharyngeal and/or oral pharyngeal swabs were
collected from patients. RNA was extracted from 200 μl of each sample followed by a two-step real-time RT-PCR.
The Anyplex™ II RV16 Detection kit was used for viral detection. The kit enabled the simultaneous detection of the
presence of 16 respiratory viruses.
Results: 150 viruses were detected: influenza viruses (44.7%) and rhinoviruses (26.7%) were the most prevalent. We
detected 13 human parainfluenza viruses (8.7%), 7 human respiratory syncytial viruses (4.7%), 6 coronaviruses (4%),
5 human metapneumoviruses (3.3%), 5 human adenoviruses (3.3%) and 1 human bocavirus (0.7%). 14 cases (6%) of
dual virus infections and one triple viral detection case were encountered. 56 (56.6%) viruses detected were found
in the 50-64 year old age group, 59 (76.6%; P < 0.001) from 65–74 year old age group and 35 (62.5%) were detected
in the ≥75 year old age group. The viral co-infections were more frequent in the 65-74 age group (9/15).
Conclusions: This pilot study demonstrates a variety of respiratory viruses in the elderly. It also highlights a high
prevalence of these viruses in this age group. We speculate from these results that the impact of respiratory viruses
other than influenza on the elderly has been considerably underestimated. A more exhaustive study seems
necessary in order to provide a more complete picture of the burden of respiratory viruses on morbidity among
adults over 50 years old in the sub-Saharan context.
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Background
Viral aetiology, prevalence and diversity data in people
with influenza like illness (ILI) and/or acute respiratory
illness (ARI) in Africa, (especially in West Africa), are
scarce and often limited to the influenza viruses’ infection.
Following the last influenza pandemic episode [1], few
global and pediatric studies were conducted in some
countries of the sub-region [2-4], and only a limited
number of studies have described the etiology of ILI
due to viruses including non-influenza respiratory
virus [5-7]. However, no study has been conducted to
describe the prevalence and the diversity of respiratory
viruses (influenza and others) in West African elderly
people. In studies done elsewhere, it is well established
that older people, when compared with younger adults,
are at greater risk of significant morbidity and mortality
from complications arising from influenza [8,9]. For
example in the United States alone, up to 40% of
non-pneumonic lower respiratory illnesses in the elderly
have been associated with respiratory viral infection
[10], and an estimated 54,000 deaths annually have
been attributed to the influenza and respiratory syncytial
viruses (RSV) [11].
It should be highlighted that in Senegal the number of
elderly people in consultation in healthcare centers for
influenza like illness (ILI) is very low. Indeed, routine
influenza monitoring in Senegal showed that samples
from people above 50 years old represent only 3.7%
of the total, over a 16 year surveillance period [4].
Some practices such as auto-medication and the use
of traditional medicine to treat ILI largely explain this
situation with the socio-economic situation being another
contributing factor.
Thus the main aim of this study was to determine
the prevalence and the diversity of respiratory viruses
associated with ILI cases in adults over 50 years old.
Methods
Recruitment and samples
The recruitment period of this prospective observational
study was from January 2009 to December 2011 inclusive.
All 232 patients aged 50 years and above presenting with
ILI during this period were enrolled in the study. It should
be noted that samples were collected in the context
of flu monitoring. An influenza sentinel surveillance
system for outpatients with ILI was established in
1996 in Senegal and became part of the WHO Global
Influenza Surveillance and Response System (GISRS).
It is coordinated locally by the National Influenza Center
(NIC) at the Institut Pasteur de Dakar.
Trained medical personnel were asked to screen all
outpatients who were attended at the sentinel sites for
signs and symptoms of ILI. The symptoms of influenza
are similar to those arising from other viral respiratory
pathogens. The inclusion criteria, according to the CDC
case definition, were sudden onset of fever (≥38°C) with
cough or sore throat fewer than 3 days in duration.
Nasal-pharyngeal and/or oral-pharyngeal swabs were
collected from each enrolled ILI case, placed in cryovials
containing 3 ml of viral transport medium (Universal
Transport Medium, COPAN Diagnostics Inc., Murrieta,
CA, USA) and stored at 4°C on site. If nasal-pharyngeal
and oral-pharyngeal swab specimens were collected from
the same patient, both swabs were placed in the same
cryovial. Upon arrival at the laboratory the specimens
were separated into 3 aliquots for analyses. The first
aliquot was used for molecular analysis for the detection
of influenza viruses (real-time reverse transcription
polymerase chain reaction or rRT-PCR detection), the
second was used for influenza virus isolation, and the
third was stored at −80°C for further analysis. The
latter was used in the present study.
For each patient who met the case definition criteria, a
form collecting demographic and clinical data was
completed.The questions included information on date of
enrollment and symptom onset, sex, age, clinical symp-
toms, previous treatments, vaccination status for influenza,
and whether or not the patient was hospitalized.
RNA extraction from clinical samples
Ribonucleic acid (RNA) extraction was performed
from 200 μl of each sample using the QIAamp Viral
RNA kit (QIAGEN, Valencia, CA, USA) according to
the manufacturer’s instructions. Each RNA sample
was eluted with 100 μl nuclease-free water before RNA
quantification with a Nanodrop apparatus (NanoDrop
Lite, Thermo Scientific).
Detection of respiratory viruses
A two-step real-time RT-PCR was performed using the
CFX96 Real-Time PCR Detection System (Bio-Rad).
cDNA synthesis step
The RevertAid First Strand cDNA Synthesis Kit (Thermo
Scientific) was used. First 1 ng of RNA was mixed with
1 μl of random hexamer primer and nuclease free water
for a final volume of 10 μl. It was then incubated at 65°C
for 5 minutes and immediately put on ice in order to
remove the secondary structures in GC-rich RNA.
For the cDNA synthesis step, 4 μl of 5X reaction
buffer, 1 μl of RNase inhibitor (20 u/μl), 2 μl of dNTP
Mix (10 mM) and 1 μl of RevertAid M-MuLV Reverse
Transcriptase (200 u/μl) were added and incubated
for 5 minutes at 25°C followed by 60 minutes at 42°C
and 70°C for 5 minutes. The cDNA product could be
used directly for the next step (PCR amplification) or
stored at −80°C until use.
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PCR detection
For viral detection, the Anyplex™ II RV16 Detection
kit (Seegene) was used. The Kit enabled simultaneous
detection of influenza A virus, influenza B virus,
human respiratory syncytial virus A, human respira-
tory syncytial virus B, human adenovirus, human
metapneumovirus, human coronavirus 229E, human
coronavirus NL63, human coronavirus OC43, human
parainfluenza virus −1, −2, −3, −4, human rhinovirus
A/B/C, human enterovirus and human bocavirus.
Reactions are duplicated in two panels (A and B) for
detection of the 16 viruses. The total reaction volume
was 20 μl for each sample (for each panel), containing
4 μl 5X RV16 A (or 5X RV16 B), 4 μl of 8-MOP solution,
4 μl of 5X Anyplex PCR Master Mix (mix well by inverting
5 times) and 8 μl of cDNA product. PCR was assessed after
95°C for 15 minutes for transcriptase reverse enzyme
inactivation, 50 cycles of 95°C for 30 seconds, 60°C
for 60 seconds and 72°C for 30 seconds. 1 additional
cycle of 55°C for 30 seconds was added for comple-
tion. The fluorescence is detected with a melting
curve step, 55°C-85°C (5 seconds/0.5°C).
Statistical analysis
Fisher’s exact test was used to verify whether the associ-
ated proportions were statistically supported and a
p-value < 0.05 was considered statistically significant.
We used the 50-64 year’ old group as the reference.
The R.15.1 tool was used to perform the analyses.
Ethical considerations
The Senegalese National Ethical Committee of the Min-
istry of Health approved the surveillance protocol as less
than minimal risk research, and written consent forms
were not required. Throughout the study, the database
was shared with the Epidemiology Department at the
Senegalese Ministry of Health and Prevention for appro-
priate public health action.
Results
Demographic and clinical information
A total of 232 patients above 50 years old were enrolled
into the study, 129 (55.8%) were women and 102 (44.2%)
were men (Table 1). Patients’ ages ranged from 51 to
97 years, with a mean age of 66 years. Ninety-nine
(42.7%) enrolled patients were between 51 and 64 years
old, 77 (33.2%) between 65 and 74 years old and 56
(24.1%) were 75 years old or older.
Fever was the most reported clinical symptom, in 213
(92.2%; 213/232) of the enrolled patients, followed by
cough (80.2%; 186/232), rhinitis (75.9%; 176/232), myalgia
(53.9%; 125/232) and pharyngitis (44%; 102/232).
Viral detection
In all, 132 (56.9%) out of the 232 patients were found to
be infected with at least one of the viruses of interest.
A total of 150 (64.6% of patients) viruses were detected.
Of these viruses, Influenza viruses (44.7%; 67/150) and
rhinoviruses (26.7%; 40/150) were the most prevalent
viruses detected (Table 2). We detected 13 human
parainfluenza viruses (3 PIV1, 4 PIV3, 6 PIV4) (8.7%), 7
human respiratory syncytial viruses (6 RSV A and 1 RSV
B) (4.7%), 6 coronaviruses (4 coronaviruses NL63, one
coronaviruses 229E and one coronavirus OC43) (4%), 5
human metapneumoviruses (3.3%), 5 human adenoviruses
(3.3%) and one human bocavirus (0.7%).
A total of 14 cases (6%) of dual virus infections
and one triple viral detection case were encountered.
Influenza viruses (13 cases) and rhinoviruses (8 cases)
were the most common type of virus found in samples
with coinfections.
Regarding the number of viruses detected per age
group, 56 (56.6%; 56/99) were from the 50-64 age group,
59 (76.6%; 59/77; P < 0.001) from the 65-74 year old age
group and 35 (62.5%; 35/56) were detected in the older
than 75 year old age group (Table 2). The viral co-
infections are more frequent in the 65-74 year old age
group (9/15) followed by the ≥75 years group (4/15).
Taking into account the clinical symptoms and viral
detection, cough, rhinitis, pharyngitis or headache were
in similar proportion in viral positive and non-positive
patients: cough was observed in 79.4% of positive












Mean age 56 y 70 y 81 y 66 y
Gender
no. (%)
Female 55 (55.5%) 41 (53.9%) 33 (58.9%) 129 (55.8%)
Male 44 (44.5%) 35 (46.1%) 23 (41.1%) 102 (44.2%)
Viral detection
rates
56 (56.6%) 59 (76.6%) 35 (62.5%) 150 (64.6%)
Clinical data
no. (%)
Fever 89 (89.9%) 71 (93.4%) 49 (87.5%) 209 (90.5%)
Cough 70 (70.7%) 68 (89.4%) 48 (85.7%) 186 (80.5%)
Rhinitis 68 (68.7%) 67 (88.2%) 41(73.2%) 176 (76.2%)
Myalgia 35 (35.3%) 59 (77.6%) 32 (57.0%) 126 (54.5%)
Pharyngitis 26 (26.3%) 48 (63.2%) 28 (50.0%) 102 (44.2%)
Sore throat 41 (41.4%) 32 (42.1%) 23 (41.1%) 96 (41.4%)
Laryngitis 02 (2.0%) 20 (26.3%) 13 (23.2%) 35 (15.1%)
Headache 13 (13.1%) 08 (10.5%) 04 (7.1%) 25 (10.8%)
Dyspnea 02 (2.0%) 05 (6.6%) 04 (7.1%) 11 (4.8%)
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patients and 77% in the negative patients group (P = 0.17),
rhinitis 79.4% and 67% (P = 0.04), pharyngitis in 45.8% and
42% (P = 0.74) respectively. In contrast myalgia symptoms
are significantly higher among viral-positive patients:
76.3% versus 25% (P < 0.001).
The pattern of the virus detection throughout the
study period is showed in the Figure 1. Influenza viruses
(A and B) were mostly detected from July to August
(between weeks 28 and 43), which corresponds to the
rainy season in Senegal. A minor detection peak is also
registered at the beginning of the year. Rhinoviruses
and parainfluenza viruses showed homogeneous detection
levels throughout the study period. Grouped, the remaining
viruses seemed to have a similar temporal pattern to that of
influenza viruses. The gap observed between weeks 18 and
22 correspond with a lack of samples from patients from
our targeted age group.
Discussion
The present study is the first description of the etiology
of respiratory viruses associated with patients with ILI in
a cohort of elderly people in the West African context.
The results obtained showed that 132 samples of the
study population out of 232 contained at least one of the
targeted respiratory viruses.
The frequency of virus detection (56.9%) among the
elderly with ILI in our study is consistent with that of
several studies already conducted. Huo et al. (2012) [12],
in a similar study in China detected at least one respira-
tory virus in 53% of patients 60 years old or older, and
Munoz et al. (2000) [13] 49% in elders in a long term
care facilities in Ontario during the 1998-1999 period.
Hasman et al. (2009) [14] detected at least one respiratory
virus in 68% patients in a study conducted in USA,
without any precision about the ages of the 154
adults. In others studies frequencies are lower. For
example Nicholson et al. (1997) [15] 43% (211/497) of
viral detection among the elderly between 60 and
90 years of old, 36% (185/512) detected in the elderly
over 65 years old in a study in China [16] and 22.2%
in a recent study in Japan [17]. It is important to
note that the technical approach used explains some
discrepancies in rates of detection: primarily in their
sensitivity and secondly in the number of targeted viruses.
Alternatively differences in rates of detection could be
due to true geographical differences in overall burden,
differences in study populations (outpatients or hospitalized
patients) and to the studies sample collection periods.
Overall, the viral detection rate in the present study is very
high as elderly people are often protected by pre-existing
antibodies from previous illnesses, maybe illnesses suffered
even decades back [18-20]. Indeed, because of pre-existing
systemic and mucosal antibodies, elderly adults have been
observed to have lower amounts of respiratory secretions
and lower viral loads compared to children [10]. Consistent
Table 2 Viral etiology of influenza-like illness cases in



















Influenza A 24 (24.2%) 20 (26%) 8 (14.3%) 52 (22.4%)
Influenza B 4 (4.0%) 10 (13%) 1 (1.8%) 15 (6.5%)
RSV 2 (2.0%) 3 (3.9%) 2 (3.6%) 7 (3.0%)
Rhinovirus 12 (12.1%) 16 (20.8%) 12 (21.4%) 40 (17.2%)
Parainfluenza 3 (3.0%) 5 (6.5%) 5 (8.9%) 13 (5.6%)
Coronavirus 6 (6.0%) 0 (0.0%) 0 (0.0%) 6 (2.3%)
HMPV 3 (3.0%) 1 (1.3%) 1 (1.8%) 5 (2.2%)
Enterovirus 2 (2.0%) 3 (3.9%) 1 (1.8%) 6 (2.3%)
Adenovirus 0 (0.0%) 0 (0.0%) 5 (8.9%) 5 (2.2%)
Bocavirus 0 (0.0%) 1 (1.3%) 0 (0.0%) 1 (0.4%)
Codetections 2 (2.0%) 9 (11.7%) 4 (7.1%) 15 (6.5%)
Figure 1 Weekly repartition of respiratory viral detection positives in patients older than 50 years in Senegal during 2009 and 2011 years.
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with this hypothesis, Falchi et al. (2011) [21] noted that the
age distribution differed significantly between positive and
negative patients, with positive patients being younger than
negative patients (OR = 0.98, IC 0.95– 0.99; P = 0.0226).
Of the 150 viruses detected in the elderly, influenza A
virus was the most common viral pathogen. Combined
with influenza B viruses, influenza viruses represented
45% (67/150) of viruses detected. This influenza detection
rate was expected as the enrollment of patients was
directed towards patients with ILI. These results are in
agreement with previous findings in the elderly [14,17,22].
Our study revealed a high detection rate of rhinoviruses
(40/150; 26.7%). Rhinovirus is the most common respira-
tory pathogen in all age groups [23]. In a previous study,
Nicholson et al. (1997) [15] showed that rhinoviruses were
responsible for a greater disease burden (activities restric-
tion, duration of illness) than that of influenza in elderly
subjects representing 52% of detected viruses. In another
study published by Greenberg (2002) [24], rhinovirus was
the most prevalent pathogen (121 isolates; 53%) of the 231
identified in upper respiratory episodes. These findings
are in concordance with the high rhinovirus detection rate
in the present study.
With lower prevalence, PIV, RSV, HCoV, HMPV,
enteroviruses, adenoviruses and bocaviruses were identi-
fied from elderly patient’ specimens and contributed
collectively to 28.7% of all ILI cases in our study.
These results show the high diversity of respiratory
viruses circulating in the elderly population. This viral
diversity supports previous results [10,12,24] and often in
similar distributions with those of the present study.
Co-infections were relatively common in this study
especially in the 65-74 years old age group (11.7%; 9/77).
The rate found in this age group was in line with the
findings of Hasman et al. (2009) [14] (11%) and Huo et al.
(2012) [12], 11.7%. Huo and colleagues, in agreement with
our results noted that co-infections were found most
commonly in adults older than 60 years of age.
Focusing on clinical symptoms, with the exception
of myalgia, our study showed no significant differences
between viral-positive and viral- negative patients with ILI.
Viral circulation observed during the study period
showed different patterns depending on the viral types. If
we consider influenza viruses, we observed a circulation
peak during the period starting in week 35 and ending in
week 44. This period corresponds to the middle of the
rainy season in Senegal. This result is further supported
by a recent study conducted by Mbayame and colleagues
[4]. These authors established clearly the seasonality
of influenza viruses in Senegal after many years of surveil-
lance with a regular circulation during the year and a peak
in the middle of the rainy season (July-August-September).
The slight peak of influenza observed at the beginning of
the year (February) is the result of the shift caused by the
recent pandemic episode. The pandemic occurred in early
2010 in Senegal with a peak in February [25]. Rhinoviruses
showed a regular yearly circulation with peaks along the
year corresponding to any rain season influence. The
remaining respiratory viruses (PIV, RSV, HCoV, HMPV,
enterovirus, adenovirus and bocavirus) were more
likely associated with ILI peak during the rainy season.
This co-circulation with influenza viruses was also seen in
a previous pediatric study in Senegal [6]. Further
studies (multiple year surveillance) are needed in order to
properly define the temporal patterns of non-influenza
virus circulation in Senegal.
Our study did have several limitations. The first weakness
is the small number of samples treated in this study. A more
exhaustive sampling would give a better representation of
the different targeted viruses in the ILI cases among the
elderly population in Senegal. Unfortunately after 16 years
of influenza sentinel monitoring we noted that the number
of elderly presenting at healthcare centers for ILI consult-
ation is rather low compared to other age groups (children
and young adults). The absence of nursing home services as
in industrial countries, the use of traditional medicine
(especially among the elderly) and economic constraints do
not facilitate such studies in the West African context.
It is worth noting that this was a retrospective study, the
database contained limited information on disease outcome
and atypical clinical symptoms in ILI patients which were
not reported. Thus the association between viral infections
(or co-infections) and severe signs could not be established.
As in previous studies it appears that co-infections were
associated with more severe signs than mono-infections
[26,27]. Without such data we could not measure the
burden of targeted respiratory viruses in older patients with
ILI. Another limitation is that our study is only focused on
outpatient’ cases; it would be interesting to investigate
hospitalized patient cases (severe cases). A final limitation
was that the study included mainly one geographic location,
Dakar, the capital city of Senegal.
Conclusion
Despite the small number of samples included, the present
pilot study demonstrates a variety of respiratory viruses in
the elderly. It also highlights a high prevalence of these
viruses in this cohort. From these results, it appears that
the impact of respiratory viruses other than influenza was
considerably underestimated. A more exhaustive study
(increasing the number of elderly patients, with a better
clinical picture and better documentation including
disease outcomes, illness duration, hospitalizations etc.),
relying on the new sentinel surveillance system (extension
of sentinel sites in others geographical areas), seems
necessary in order to provide a more complete picture of
the burden of respiratory viruses on morbidity among
adults over 50 years old in the sub-Saharan context.
Dia et al. BMC Infectious Diseases 2014, 14:189 Page 5 of 6
http://www.biomedcentral.com/1471-2334/14/189
Abbreviations
ILI: Influenza-like illness; rRT-PCR: Real-time reverse transcription polymerase
chain reaction; WHO: World Health Organization; cDNA: Complementary
deoxyribonucleic acid; RNA: Ribonuleic acid; GISN: Global Influenza
Surveillance Network; NIC: National Influenza Center; PIV: Parainfluenza virus;
RSV: Respiratory syncytial virus; HCoV: Human coronavirus; HMPV: Human
metapneumovirus.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
The work presented here was carried out in collaboration between all
authors. MNN and OMD, defined the research and revised the manuscript;
ND performed and coordinated technical work, wrote the draft and revisions
of the paper; DK performed the main technical part of this work; EAKC and
AF participated in the technical work; DG and EAKC participated in data
management and analysis; VR revised the manuscript and participated in the
monitoring of the surveillance sites; FDS participated in the monitoring of
the surveillance sites. All authors have contributed to, seen and approved
the manuscript.
Acknowledgements
The authors thank Dr Abdou Salam Gueye, Associate Director for science at
the US Centers for Disease Control (CDC) in Ivory Coast, for his great help in
the revisions of this paper, especially for the English language. Many thanks
to Oumy Niass (PhD student, Immunology Unit, IPD) for her help in the
statistical analyses.
This work was funded by Institut Pasteur de Dakar, Senegal.
Author details
1Unit of Medical Virology, Institut Pasteur de Dakar, Unité de Virologie
Médicale, Dakar, BP; 220, Dakar, Senegal. 2Institut Pasteur de Dakar, Unité
d’Epidémiologie des maladies infectieuses, Dakar, Sénégal.
Received: 4 November 2013 Accepted: 3 April 2014
Published: 8 April 2014
References
1. Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, Garten RJ, Gubareva LV,
Xu X, Bridges CB, Uyeki TM: Emergence of a novel swine-origin influenza
A (H1N1) virus in humans. N Engl J Med 2009, 360:2605–2615.
2. Bonney JH, Kronmann KC, Lindan CP, Asante IA, Parbie P, Aboagye J,
Amankwah J, Odoom JK, Adjabeng M, Nzussouo NT, Ahadzie L, Barthel RV,
Cornelius C, Amofah G, Oyofo B, Ampofo WK: Virological surveillance of
influenza-like illness among children in Ghana, 2008-2010. J Infect Dis
2012, 206(Suppl 1):S108–S113.
3. Dalhatu IT, Medina-Marino A, Olsen SJ, Hwang I, Gubio AB, Ekanem EE,
Coker EB, Akpan H, Adedeji AA: Influenza viruses in Nigeria, 2009-2010:
results from the first 17 months of a national influenza sentinel
surveillance system. J Infect Dis 2012, 206(Suppl 1):S121–S128.
4. Niang MN, Dosseh A, Ndiaye K, Sagna M, Gregory V, Goudiaby D, Hay A,
Diop OM: Sentinel surveillance for influenza in Senegal, 1996-2009.
J Infect Dis 2012, 206(Suppl 1):S129–S135.
5. Razanajatovo NH, Richard V, Hoffmann J, Reynes JM, Razafitrimo GM,
Randremanana RV, Heraud JM: Viral etiology of influenza-like illnesses in
Antananarivo, Madagascar, July 2008 to June 2009. PLoS One 2011,
6(3):e17579. Doi: 10.1371/journal.pone.0017579.
6. Niang MN, Diop OM, Sarr FD, Goudiaby D, Malou-Sompy H, Ndiaye K, Vabret
A, Baril L: Viral etiology of respiratory infections in children under 5 years
old living in tropical rural areas of Senegal: the EVIRA project. J Med Virol
2010, 82(5):866–872.
7. Njouom R, Yekwa EL, Cappy P, Vabret A, Boisier P, Rousset D: Viral etiology
of influenza-like illnesses in Cameroon, January-December 2009. J Infect
Dis 2012, 206(Suppl 1):S29–S35.
8. Fleming DM, Elliot AJ: The impact of influenza on the health and health
care utilisation of elderly people. Vaccine 2005, 23(Suppl1):S1–S9.
9. Newall AT, Wood JG, Macintyre CR: Influenza-related hospitalisation and death
in Australians aged 50 years and older. Vaccine 2008, 26(17):2135–2141.
10. Jartti L, Langen H, Söderlund-Venermo M, Vuorinen T, Ruuskanen O, Jartti T:
New respiratory viruses and the elderly. Open Respir Med J 2011, 5:61–69.
11. Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ,
Fukuda K: Mortality associated with influenza and respiratory syncytial
virus in the United States. JAMA 2003, 289:179–186.
12. Huo X, Qin Y, Qi X, Zu R, Tang F, Li L, Hu Z, Zhu F: Surveillance of 16
respiratory viruses in patients with influenza-like illness in Nanjing,
China. J Med Virol 2012, 84(12):1980–1984.
13. Munoz FM, Galasso GJ, Gwaltney JM Jr, Hayden FG, Murphy B, Webster R,
Wright P, Couch RB: Current research on influenza and other respiratory
viruses: II international symposium. Antiviral Res 2000, 46(2):91–124.
14. Hasman H, Pachucki CT, Unal A, Nguyen D, Devlin T, Peeples ME, Kwilas SA:
Aetiology of influenza-like illness in adults includes parainfluenzavirus
type 4. J Med Microbiol 2009, 58(Pt 4):408–413.
15. Nicholson KG, Kent J, Hammersley V, Cancio E: Acute viral infections of
upper respiratory tract in elderly people living in the community:
comparative, prospective, population based study of disease burden.
BMJ 1997, 315(7115):1060–1064.
16. Yang Y, Wang Z, Ren L, Wang W, Vernet G, Paranhos-Baccalà G, Jin Q, Wang J:
Influenza A/H1N1 2009 pandemic and respiratory virus infections, Beijing,
2009-2010. PLoS One 2012, 7(9):e45807. doi: 10.1371/journal.pone.0045807.
Epub 2012 Sep 20.
17. Ikematsu H, Takeuchi Y, Rosenlund M, Kawai N, Shimamura R, Hirata M,
Iwaki N: The post-infection outcomes of influenza and acute respiratory
infection in patients above 50 years of age in Japan: an observational
study. Influenza Other Respi Viruses 2012, 6(3):211–217.
18. Subbarao K, Klimov A, Katz J, Regnery H, Lim W, Hall H, Perdue M, Swayne D,
Bender C, Huang J, Hemphill M, Rowe T, Shaw M, Xu X, Fukuda K, Cox N:
Characterization of an avian influenza A (H5N1) virus isolated from a child
with a fatal respiratory illness. Science 1998, 279:393–396.
19. Fowlkes AL, Arguin P, Biggerstaff MS, Gindler J, Blau D, Jain S, Dhara R,
McLaughlin J, Turnipseed E, Meyer JJ, Louie JK, Siniscalchi A, Hamilton JJ,
Reeves A, Park SY, Richter D, Ritchey MD, Cocoros NM, Blythe D, Peters S,
Lynfield R, Peterson L, Anderson J, Moore Z, Williams R, McHugh L, Cruz C,
Waters CL, Page SL, McDonald CK, et al: Epidemiology of 2009 pandemic
influenza a (H1N1) deaths in the United States, April-July 2009. Clin Infect
Dis 2011, 52(Suppl 1):S60–S68.
20. Centers for Disease Control and Prevention (CDC): Outbreaks of 2009
pandemic influenza A (H1N1) among long-term-care facility residents–three
states, 2009. MMWR Morb Mortal Wkly Rep 2010, 59:74–77.
21. Falchi A, Turbelin C, Andreoletti L, Arena C, Blanchon T, Bonmarin I, Hanslik T,
Leruez-Ville M, De Lamballerie X, Carrat F: Nationwide surveillance of 18
respiratory viruses in patients with influenza-like illnesses: a pilot feasibility
study in the French Sentinel network. J Med Virol 2011, 83:1451–1457.
22. Widmer K, Zhu Y, Williams JV, Griffin MR, Edwards KM, Talbot HK: Rates of
hospitalizations for respiratory syncytial virus, human metapneumovirus,
and influenza virus in older adults. J Infect Dis 2012, 206(1):56–62.
23. Knipe DM, Howley PM: Fields Virology. 5th edition. Philadelphia, PA:
Lippincott Williams & Wilkins; 2007.
24. Greenberg SB: Viral respiratory infections in elderly patients and patients
with chronic obstructive pulmonary disease. Am J Med 2002,
112(Suppl 6A):28S–32S. Review.
25. Dia N, Ndiaye MN, Monteiro Mde L, Koivogui L, Bara MO, Diop OM: A
subregional analysis of epidemiologic and genetic characteristics of
influenza A(H1N1)pdm09 in Africa: Senegal, Cape Verde, Mauritania, and
Guinea, 2009-2010. Am J Trop Med Hyg 2013, 88(5):946–953.
26. Frobert E, Escuret V, Javouhey E, Casalegno JS, Bouscambert-Duchamp M,
Moulinier C, Gillet Y, Lina B, Floret D, Morfin F: Respiratory viruses in
children admitted to hospital intensive care units: evaluating the CLART1
Pneumovir DNA array. J Med Virol 2011, 83:150–155.
27. Wolf DG, Greenberg D, Kalkstein D, Shemer-Avni Y, Givon-Lavi N, Saleh N,
Goldberg MD, Dagan R: Comparison of human metapneumovirus, respiratory
syncytial virus and influenza A virus lower respiratory tract infections in
hospitalized young children. Pediatr Infect Dis J 2006, 25:320–324.
doi:10.1186/1471-2334-14-189
Cite this article as: Dia et al.: Respiratory viruses associated with
patients older than 50 years presenting with ILI in Senegal, 2009 to
2011. BMC Infectious Diseases 2014 14:189.
Dia et al. BMC Infectious Diseases 2014, 14:189 Page 6 of 6
http://www.biomedcentral.com/1471-2334/14/189
